Pamidronate therapy for lung cancer patients with bone metastasis
Oura, S.; Yoshimasu, T.; Sakurai, T.; Nakamura, T.; Kokawa, Y.; Matsuyama, K.; Ohta, F.; Naito, Y.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(7): 1057-1060
2000
ISSN/ISBN: 0385-0684 PMID: 10925695 Document Number: 524002
Document emailed within 1 workday
Related Documents
Maekawa, Y.; Furuya, Y.; Toyokawa, A.; Kinugasa, T.; Fukano, S.; Sekimoto, K.; Kohno, N. 1998: A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(12): 1959-1963Iguchi, H.; Tanaka, S.; Ozawa, Y.; Kashiwakuma, T.; Kimura, T.; Hiraga, T.; Ozawa, H.; Kono, A. 1996: An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis Cancer Research 56(17): 4040-4043
Kanda, K.; Waki, S.; Uchimura, M.; Kida, H.; Narita, K.; Harada, N. 1990: A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2421-2424
Theriault, R. 1996: Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients British Journal of Clinical Practice. Suppl 87: 8
Hayashi, S.; Hanamura, T. 2011: Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy Clinical Calcium 21(3): 389-396
Miura, S.; Kagamu, H.; Saijyo, Y. 2012: Management of bone metastasis originating from lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(8): 1183-1186
Kraj, M.; Pogłód, R.; Pawlikowski, J.; Maj, S.; Nasiłowska, B. 2000: Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. the results of the first 12 months of pamidronate therapy Acta Poloniae Pharmaceutica 57 Suppl: 113-116
Suzuki, N.; Suzuki, S.; Tominaga, K.; Hoshino, M.; Naruse, H.; Fukushima, M.; Murakami, M. 2012: A case report of recurrent lung metastasis after surgery for rectal cancer for which lung radiofrequency ablation therapy and long-term administration of FOLFIRI were effective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2267-2269
Dibekoglu, C.; Turanli, S.; Karaman, N.; Ozcelik, K.C.; Erdogan, O. 2015: Bone fracture in breast cancer patients with isolated bone metastasis Chirurgia 110(1): 43-48
Hirano, Y.; Oda, M.; Tsunezuka, Y.; Ishikawa, N.; Watanabe, G. 2005: Long-term survival cases of lung cancer presented as solitary bone metastasis Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 11(6): 401-404
Haas, R.L.; Bartelink, H. 1995: Bone pain in patients with cancer is not always due to bone metastasis Nederlands Tijdschrift Voor Geneeskunde 139(7): 305-308
Dong, Q.; Feng, J.; Huang, J.; Bao, G.; Sha, H.; Gu, W. 2002: Vascular endothelial growth factor promotes hematogenous metastasis of cancer cells in patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 24(2): 142-146
Tanaka, S.; Morikawa, Y. 1991: Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(6): 1039-1041
Kubota, K. 2017: I. Management of Brain Metastasis in Patients with Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(6): 475-478
Muhammet Hacioglu, B.; Kostek, O.; Erdogan, B.; Uzunoglu, S.; Cicin, I. 2017: Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 586-591
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Tamura, J.; Nakauchi, M.; Nakayama, Y.; Kitaguchi, K.; Sakikubo, M.; Ura, K.; Taira, K.; Ohe, H.; Yoshikawa, A.; Ishigami, S.-I.; Baba, N. 2009: A case of interstitial pneumonitis induced by FOLFIRI+bevacizumab combination therapy for liver and lung metastasis of colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2665-2668
Guo, Y.; Zhang, R.; Wang, W.; Ma, Z.; Xue, Q.; Deng, J.; Liang, H. 2016: Relevant factors analysis on the survival of gastric cancer patients with lung metastasis Zhonghua Wei Chang Wai Ke Za Zhi 19(1): 58-61
Kawano, R.; Hata, E.; Ikeda, S.; Yokota, T. 2008: Lobe-specific skip nodal metastasis in non-small cell lung cancer patients Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 14(1): 9-14
Turk, F.; Gursoy, S.; Yaldiz, S.; Yuncu, G.; Yazgan, S.; Basok, O. 2011: Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients Minerva Chirurgica 66(6): 509-516